SUPRANE Drug Patent Profile
✉ Email this page to a colleague
When do Suprane patents expire, and when can generic versions of Suprane launch?
Suprane is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in SUPRANE is desflurane. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Suprane
A generic version of SUPRANE was approved as desflurane by SHANGHAI HENGRUI on February 26th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUPRANE?
- What are the global sales for SUPRANE?
- What is Average Wholesale Price for SUPRANE?
Summary for SUPRANE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 35 |
Patent Applications: | 1,352 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SUPRANE |
What excipients (inactive ingredients) are in SUPRANE? | SUPRANE excipients list |
DailyMed Link: | SUPRANE at DailyMed |
![SUPRANE drug patent expirations Drug patent expirations by year for SUPRANE](/p/graph/s/t/SUPRANE-patent-expirations.png)
![Drug Prices for SUPRANE](/p/graph/drug-price/SUPRANE.png)
Recent Clinical Trials for SUPRANE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute, Egypt | N/A |
Sefako Makgatho Health Sciences University | N/A |
GAMZE PİRİNÇ ŞAŞIOĞLU | N/A |
Pharmacology for SUPRANE
Drug Class | General Anesthetic |
Physiological Effect | General Anesthesia |
Paragraph IV (Patent) Challenges for SUPRANE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SUPRANE | Inhalation | desflurane | 99.9% | 020118 | 1 | 2008-09-11 |
US Patents and Regulatory Information for SUPRANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | SUPRANE | desflurane | LIQUID;INHALATION | 020118-001 | Sep 18, 1992 | AN | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUPRANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | SUPRANE | desflurane | LIQUID;INHALATION | 020118-001 | Sep 18, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | SUPRANE | desflurane | LIQUID;INHALATION | 020118-001 | Sep 18, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUPRANE
See the table below for patents covering SUPRANE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2100658 | ⤷ Sign Up | |
Finland | 933326 | ⤷ Sign Up | |
South Korea | 100198205 | ⤷ Sign Up | |
European Patent Office | 0568564 | RECIPIENT POUR AGENT ANESTHESIQUE LIQUIDE (A CONTAINER FOR LIQUID ANAESTHETIC AGENT) | ⤷ Sign Up |
Japan | H0376286 | ⤷ Sign Up | |
Japan | H06504463 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SUPRANE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0285237 | 95C0008 | Belgium | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL, HEMIHYDRATE; NAT. REGISTRATION NO/DATE: NL 19489 19941107; FIRST REGISTRATION: FR - NL 19489 19941107 |
0285237 | 94C0006 | France | ⤷ Sign Up | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |